Search the site

Case Study: NEC

NEC Australia has joined forces with The Kids Research Institute Australia to ensure a state-of-the-art ICT system is in place at the new Perth Children’s Hospital.

Schools

Tailored to spark curiosity and link directly to the Australian curriculum, our schools program engages young minds and bridges the gap between classroom learning and cutting-edge medical research.

Schools Program Enquiry

Register for our Schools Program.

Home School Inquiry Form

Everything you need to know to book a home schooler excursion at the The Kids Discovery Centre.

Discover Series: Cancer

What would you discover to help a child? At The Kids, our researchers are committed to Cancer research that makes a real difference.

Fearless Xander: Why we research children's cancers

Ten-year-old Xander has been through more than most kids of his age – specifically, three-and-a-half years of gruelling chemotherapy to treat leukaemia.

The Power of Why

Our job is to find the answers. It's helping us change kids' lives. See the "why?"s we're asking and answering.

A diagnostic test for acute rheumatic fever (pilot study)

Currently there are no diagnostic tests for ARF, and no treatments targeting immune responses to improve disease outcomes.

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical

A phase 3, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety and tolerability of V114 in healthy infants (PNEULINK)

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical